Jonathan Barratt

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 60

Top Venues

Clinical journal of the American Society of Nephrology : CJASN

Journal of the American Society of Nephrology : JASN

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

University of Leicester

University of Leicester (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Leicester Sep 01 1996

United Kingdom

Professor of Renal Medicine :: Cardiovascular Sciences

Education History

University of Leicester Sep 01 1996 - Apr 01 2000

United Kingdom

PHD :: Medicine

University of Manchester Sep 01 1988 - Jun 01 1989

United Kingdom

BSC :: Medical School

Publications

Louise Oni, Rona M Smith, Alan David Salama, Jonathan Barratt, Howard Trachtman, Moin A Saleem
Bridging the 13-Year Evidence Gap: A Time for Age-Inclusive Research. Journal of the American Society of Nephrology : JASN 35 (4) (2024)
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, Shaka Martin, Alina Jiletcovici, Frank Dellanna, Tadao Akizawa, Jonathan Barratt
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials. Advances in therapy (2024)
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, Sho Mizokawa, Yuichiro Ito, Frank Dellanna, Jonathan Barratt, Tadao Akizawa
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan. Advances in therapy 41 (4) (2024)
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, Shaka Martin, Alina Jiletcovici, Frank Dellanna, Tadao Akizawa, Jonathan Barratt
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials. Advances in therapy 41 (4) (2024)
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, Sho Mizokawa, Yuichiro Ito, Frank Dellanna, Jonathan Barratt, Tadao Akizawa
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan. Advances in therapy (2024)
Louise Oni, Rona M Smith, Alan David Salama, Jonathan Barratt, Howard Trachtman, Moin A Saleem
Bridging the 13-Year Evidence Gap: A Time for Age-Inclusive Research. Journal of the American Society of Nephrology : JASN 35 (4) (2024)
Jonathan Barratt, Adrian Liew, See Cheng Yeo, Anders Fernström, Sean J Barbour, Christopher John Sperati, Russell Villanueva, Ming-Ju Wu, Dazhe Wang, Anna Borodovsky, Prajakta Badri, Elena Yureneva, Ishir Bhan, Daniel Cattran, null null
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial. Clinical journal of the American Society of Nephrology : CJASN 19 (4) (2024)
Shanshan Yu, Xiang Li, Ting Wang, Jingyi Li, Hongzhi Li, Ying Xu, Yanling Hu, Fubin Zhu, Jin-Wei Wang, Tianhe Wang, Bin Zhu, Xu-Jie Zhou, Hong Zhang, Jicheng Lv, Jonathan Barratt, Binghai Zhao
B Cell Epigenetic Modulation of IgA Response by 5-Azacytidine and IgA Nephropathy. Journal of the American Society of Nephrology : JASN (2024)
Louise Oni, Rona M Smith, Alan David Salama, Jonathan Barratt, Howard Trachtman, Moin A Saleem
Bridging the 13-Year Evidence Gap: A Time for Age-Inclusive Research. Journal of the American Society of Nephrology : JASN (2024)
Edmund J Lamb, Jonathan Barratt, Elizabeth A Brettell, Paul Cockwell, R Nei Dalton, Jonathan J Deeks, Gillian Eaglestone, Tracy Pellatt-Higgins, Philip A Kalra, Kamlesh Khunti F MedSci, Fiona C Loud, Ryan S Ottridge, Aisling Potter, Ceri Rowe, Katie Scandrett, Alice J Sitch, Paul E Stevens, Claire C Sharpe, Bethany Shinkins, Alison Florence Smith, Andrew John Sutton, Maarten W Taal
Accuracy of glomerular filtration rate estimation using creatinine and cystatin C for identifying and monitoring moderate chronic kidney disease: the eGFR-C study. Health technology assessment (Winchester, England) 28 (35) (2024)
Edmund J Lamb, Jonathan Barratt, Elizabeth A Brettell, Paul Cockwell, R Nei Dalton, Jonathan J Deeks, Gillian Eaglestone, Tracy Pellatt-Higgins, Philip A Kalra, Kamlesh Khunti F MedSci, Fiona C Loud, Ryan S Ottridge, Aisling Potter, Ceri Rowe, Katie Scandrett, Alice J Sitch, Paul E Stevens, Claire C Sharpe, Bethany Shinkins, Alison Florence Smith, Andrew John Sutton, Maarten W Taal
Accuracy of glomerular filtration rate estimation using creatinine and cystatin C for identifying and monitoring moderate chronic kidney disease: the eGFR-C study. Health technology assessment (Winchester, England) 28 (35) (2024)
Jonathan Barratt, Adrian Liew, See Cheng Yeo, Anders Fernström, Sean J Barbour, Christopher John Sperati, Russell Villanueva, Ming-Ju Wu, Dazhe Wang, Anna Borodovsky, Prajakta Badri, Elena Yureneva, Ishir Bhan, Daniel Cattran, null null
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial. Clinical journal of the American Society of Nephrology : CJASN (2024)
Edmund J Lamb, Jonathan Barratt, Elizabeth A Brettell, Paul Cockwell, R Nei Dalton, Jonathan J Deeks, Gillian Eaglestone, Tracy Pellatt-Higgins, Philip A Kalra, Kamlesh Khunti F MedSci, Fiona C Loud, Ryan S Ottridge, Aisling Potter, Ceri Rowe, Katie Scandrett, Alice J Sitch, Paul E Stevens, Claire C Sharpe, Bethany Shinkins, Alison Florence Smith, Andrew John Sutton, Maarten W Taal
Accuracy of glomerular filtration rate estimation using creatinine and cystatin C for identifying and monitoring moderate chronic kidney disease: the eGFR-C study. Health technology assessment (Winchester, England) 28 (35) (2024)
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, Shaka Martin, Alina Jiletcovici, Frank Dellanna, Tadao Akizawa, Jonathan Barratt
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials. Advances in therapy 41 (4) (2024)
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, Sho Mizokawa, Yuichiro Ito, Frank Dellanna, Jonathan Barratt, Tadao Akizawa
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan. Advances in therapy 41 (4) (2024)
Jonathan Barratt, Adrian Liew, See Cheng Yeo, Anders Fernström, Sean J Barbour, Christopher John Sperati, Russell Villanueva, Ming-Ju Wu, Dazhe Wang, Anna Borodovsky, Prajakta Badri, Elena Yureneva, Ishir Bhan, Daniel Cattran, null null
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial. Clinical journal of the American Society of Nephrology : CJASN 19 (4) (2024)
Jonathan Barratt, Adrian Liew, See Cheng Yeo, Anders Fernström, Sean J Barbour, Christopher John Sperati, Russell Villanueva, Ming-Ju Wu, Dazhe Wang, Anna Borodovsky, Prajakta Badri, Elena Yureneva, Ishir Bhan, Daniel Cattran, null null
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial. Clinical journal of the American Society of Nephrology : CJASN 19 (4) (2024)
Haresh Selvaskandan, Jonathan Barratt
Dynamic Individualized Risk Prediction in IgA Nephropathy: Entering the Era of Artificial Intelligence. Clinical journal of the American Society of Nephrology : CJASN 19 (7) (2024)
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, Sho Mizokawa, Yuichiro Ito, Frank Dellanna, Jonathan Barratt, Tadao Akizawa
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan. Advances in therapy 41 (4) (2024)
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, Sho Mizokawa, Yuichiro Ito, Frank Dellanna, Jonathan Barratt, Tadao Akizawa
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan. Advances in therapy 41 (4) (2024)
Jonathan Barratt, Adrian Liew, See Cheng Yeo, Anders Fernström, Sean J Barbour, Christopher John Sperati, Russell Villanueva, Ming-Ju Wu, Dazhe Wang, Anna Borodovsky, Prajakta Badri, Elena Yureneva, Ishir Bhan, Daniel Cattran, null null
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial. Clinical journal of the American Society of Nephrology : CJASN 19 (4) (2024)
Haresh Selvaskandan, Jonathan Barratt
Dynamic Individualized Risk Prediction in IgA Nephropathy: Entering the Era of Artificial Intelligence. Clinical journal of the American Society of Nephrology : CJASN 19 (7) (2024)
Haresh Selvaskandan, Jonathan Barratt
Dynamic Individualized Risk Prediction in IgA Nephropathy: Entering the Era of Artificial Intelligence. Clinical journal of the American Society of Nephrology : CJASN 19 (7) (2024)
Haresh Selvaskandan, Jonathan Barratt
Dynamic Individualized Risk Prediction in IgA Nephropathy: Entering the Era of Artificial Intelligence. Clinical journal of the American Society of Nephrology : CJASN 19 (7) (2024)
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, Shaka Martin, Alina Jiletcovici, Frank Dellanna, Tadao Akizawa, Jonathan Barratt
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials. Advances in therapy 41 (4) (2024)
Takayuki Hamano, Yusuke Yamaguchi, Kashia Goto, Shaka Martin, Alina Jiletcovici, Frank Dellanna, Tadao Akizawa, Jonathan Barratt
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Four Global Roxadustat Phase 3 Trials. Advances in therapy 41 (4) (2024)
Louise Oni, Rona M Smith, Alan David Salama, Jonathan Barratt, Howard Trachtman, Moin A Saleem
Bridging the 13-Year Evidence Gap: A Time for Age-Inclusive Research. Journal of the American Society of Nephrology : JASN 35 (4) (2024)
Louise Oni, Rona M Smith, Alan David Salama, Jonathan Barratt, Howard Trachtman, Moin A Saleem
Bridging the 13-Year Evidence Gap: A Time for Age-Inclusive Research. Journal of the American Society of Nephrology : JASN 35 (4) (2024)
Haresh Selvaskandan, Jonathan Barratt
Dynamic Individualized Risk Prediction in IgA Nephropathy: Entering the Era of Artificial Intelligence. Clinical journal of the American Society of Nephrology : CJASN (2024)
Louise Oni, Rona M Smith, Alan David Salama, Jonathan Barratt, Howard Trachtman, Moin A Saleem
Bridging the 13-Year Evidence Gap: A Time for Age-Inclusive Research. Journal of the American Society of Nephrology : JASN (2024)
Louise Oni, Rona M Smith, Alan David Salama, Jonathan Barratt, Howard Trachtman, Moin A Saleem
Bridging the 13-Year Evidence Gap: A Time for Age-Inclusive Research. Journal of the American Society of Nephrology : JASN 35 (4) (2024)
Jonathan Barratt, Jens Kristensen, Christian Pedersen, Markus Jerling
Insights on Nefecon ® , a Targeted-Release Formulation of Budesonide and Its Selective Immunomodulatory Effects in Patients with IgA Nephropathy. Drug design, development and therapy 18 (2024)
Jonathan Barratt, Jens Kristensen, Christian Pedersen, Markus Jerling
Insights on Nefecon ® , a Targeted-Release Formulation of Budesonide and Its Selective Immunomodulatory Effects in Patients with IgA Nephropathy. Drug design, development and therapy 18 (2024)
Chee Kay Cheung, Suceena Alexander, Heather N Reich, Haresh Selvaskandan, Hong Zhang, Jonathan Barratt
The pathogenesis of IgA nephropathy and implications for treatment. Nature reviews. Nephrology (2024)
Jonathan Barratt, Frank Dellanna, Jose Portoles, Gabriel Choukroun, Luca De Nicola, James Young, Nada Dimković, Michael Reusch
Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies. Advances in therapy (2023)
Michelle N Rheault, Charles E Alpers, Jonathan Barratt, Stewart Bieler, Pietro A Canetta, Dong-Wan Chae, Gaia Coppock, Ulysses Diva, Loreto Gesualdo, Hiddo J L Heerspink, Jula K Inrig, Gianna M Kirsztajn, Donald Kohan, Radko Komers, Laura A Kooienga, Kenneth Lieberman, Alex Mercer, Irene L Noronha, Vlado Perkovic, Jai Radhakrishnan, William Rote, Brad Rovin, Vladimir Tesar, Hernán Trimarchi, James Tumlin, Muh Geot Wong, Howard Trachtman, null null
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis. The New England journal of medicine (2023)
Chee Kay Cheung, Jonathan Barratt, Kevin J Carroll, Richard A Lafayette, Adrian Liew, Yusuke Suzuki, Vladimir Tesar, Hernán Trimarchi, Muh Geot Wong, Hong Zhang, Vlado Perkovic, Dana V Rizk
Targeting APRIL in the Treatment of IgA Nephropathy. Clinical journal of the American Society of Nephrology : CJASN (2023)
Sandra A Lewis, Kevin J Carroll, Todd DeVries, Jonathan Barratt
Conditional power and information fraction calculations at an interim analysis for random coefficient models. Pharmaceutical statistics (2023)
Courtney Jane Lightfoot, Thomas James Wilkinson, Michelle Hadjiconstantinou, Matthew P M Graham-Brown, Jonathan Barratt, Christopher Brough, James O Burton, Jenny Hainsworth, Vicki Johnson, Maria Martinez, Andrew Christopher Nixon, Victoria Pursey, Sally Schreder, Noemi Vadaszy, Lucina Wilde, Fiona C Willingham, Hannah M L Young, Thomas Yates, Melanie Jane Davies, Alice C Smith
The Codevelopment of "My Kidneys & Me": A Digital Self-management Program for People With Chronic Kidney Disease. Journal of medical Internet research 24 (11) (2022)
Bingxin Yu, Sufang Shi, Jicheng Lv, Lijun Liu, Xujie Zhou, Li Zhu, Pei Chen, Hongyu Yang, Zi Wang, Suxia Wang, Jonathan Barratt, Hong Zhang
Rapidly progressive IgA nephropathy: clinicopathological characteristics and outcomes assessed according to the revised definition of the KDIGO 2021 Guideline. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 37 (12) (2022)
Chee Kay Cheung, John P Dormer, Jonathan Barratt
The role of complement in glomerulonephritis - are novel therapies ready for prime time? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)
Sarah Mayer-Hain, Kathleen Gebhardt, Matthias Neufeld, Jan M Ehrchen, Karen Molyneux, Jonathan Barratt, Eva Nattkemper, Dennis Gerloff, Johannes Roth, Thomas Vogl, Karin I Pappelbaum, Cord Sunderkoetter
Systemic Activation of Neutrophils by Immune Complexes Is Critical to IgA Vasculitis. Journal of immunology (Baltimore, Md. : 1950) 209 (6) (2022)
Chee Kay Cheung, Jonathan Barratt
Further Evidence for the Mucosal Origin of Pathogenic IgA in IgA Nephropathy. Journal of the American Society of Nephrology : JASN 33 (5) (2022)
Jonathan Barratt, Izabella Pawluczyk, Haresh Selvaskandan
Clinical application of microRNAs in glomerular diseases. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)
Chee Kay Cheung, Arun Rajasekaran, Jonathan Barratt, Dana V Rizk
An Update on the Current State of Management and Clinical Trials for IgA Nephropathy. Journal of clinical medicine 10 (11) (2021)
Simon A Carter, Liz Lightstone, Dan Cattran, Allison Tong, Arvind Bagga, Sean J Barbour, Jonathan Barratt, John Boletis, Dawn J Caster, Rosanna Coppo, Fernando C Fervenza, Jürgen Floege, Michelle A Hladunewich, Jonathan J Hogan, Arthur Richard Kitching, Richard A Lafayette, Ana Malvar, Jai Radhakrishnan, Brad H Rovin, Nicole Jane Scholes-Robertson, Hernán Trimarchi, Hong Zhang, Samaya Anumudu, Yeoungjee Cho, Talia Gutman, Emma O'Lone, Andrea K Viecelli, Eric Hoi Kit Au, Karolis Azukaitis, Amanda Baumgart, Amelie Bernier-Jean, Louese Dunn, Martin Howell, Angela Ju, Charlotte Logeman, Melissa Stephanie Nataatmadja, Benedicte Sautenet, Ankit Sharma, Jonathan C Craig, null null
A Core Outcome Set for Trials in Glomerular Disease: A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder Workshops. Clinical journal of the American Society of Nephrology : CJASN 17 (1) (2021)
Hongzhi Li, Zhichao Chen, Weitian Chen, Jingyi Li, Yunshuang Liu, Hongchuang Ma, Mingming Shi, Xuelian Sun, Xiusong Yao, Zhijun Li, Izabella Z A Pawluczyk, Shuchen Zhang, Jonathan Barratt, Jicheng Lv, Kai Wang, Binghai Zhao
MicroRNA-23b-3p Deletion Induces an IgA Nephropathy-like Disease Associated with Dysregulated Mucosal IgA Synthesis. Journal of the American Society of Nephrology : JASN 32 (10) (2021)
Jonathan Barratt
Corticosteroids Should Be Used to Treat Slowly Progressive IgA Nephropathy: CON. Kidney360 2 (7) (2021)
Jonathan Barratt, Wladyslaw Sulowicz, Michael Schömig, Ciro Esposito, Michael Reusch, James Young, Botond Csiky
Efficacy and Cardiovascular Safety of Roxadustat in Dialysis-Dependent Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies. Advances in therapy 38 (10) (2021)
Izabella Z A Pawluczyk, Haresh Selvaskandan, Jonathan Barratt
The Non-Coding RNA Landscape in IgA Nephropathy-Where Are We in 2021? Journal of clinical medicine 10 (11) (2021)
Jonathan Barratt, Branislav Andric, Avtandil Tataradze, Michael Schömig, Michael Reusch, Udaya Valluri, Christophe Mariat
Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES). Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 36 (9) (2021)
Scott Taylor, Molly Whitfield, Jonathan Barratt, Athanasios Didangelos
The Metalloproteinase ADAMTS5 Is Expressed by Interstitial Inflammatory Cells in IgA Nephropathy and Is Proteolytically Active on the Kidney Matrix. Journal of immunology (Baltimore, Md. : 1950) 205 (8) (2020)
Simon A Carter, Talia Gutman, Charlotte Logeman, Dan Cattran, Liz Lightstone, Arvind Bagga, Sean J Barbour, Jonathan Barratt, John Boletis, Dawn Caster, Rosanna Coppo, Fernando C Fervenza, Jürgen Floege, Michelle Hladunewich, Jonathan J Hogan, Arthur Richard Kitching, Richard A Lafayette, Ana Malvar, Jai Radhakrishnan, Brad H Rovin, Nicole Scholes-Robertson, Hérnan Trimarchi, Hong Zhang, Karolis Azukaitis, Yeoungjee Cho, Andrea K Viecelli, Louese Dunn, David Harris, David Wayne Johnson, Peter G Kerr, Paul Laboi, Jessica Ryan, Jenny I Shen, Lorena Ruiz, Angela Yee-Moon Wang, Achilles Hoi Kan Lee, Samuel K Fung, Matthew Ka-Hang Tong, Armando Teixeira-Pinto, Martin Wilkie, Stephen I Alexander, Jonathan C Craig, Allison Tong, null null
Identifying Outcomes Important to Patients with Glomerular Disease and Their Caregivers. Clinical journal of the American Society of Nephrology : CJASN 15 (5) (2020)
Haresh Selvaskandan, Chee Kay Cheung, Masahiro Muto, Jonathan Barratt
New strategies and perspectives on managing IgA nephropathy. Clinical and experimental nephrology 23 (5) (2019)
Chee Kay Cheung, Jonathan Barratt
Biomarkers to Predict Progression in IgA Nephropathy. Clinical journal of the American Society of Nephrology : CJASN 14 (10) (2019)
Ruth H Green, Val Evans, Sheona MacLeod, Jonathan Barratt
A qualitative study of the perspectives of key stakeholders on the delivery of clinical academic training in the East Midlands. JRSM open 9 (2) (2018)
Suceena Alexander, George T John, Anila Korula, T S Vijayakumar, Vinoi George David, Anjali Mohapatra, Anna T Valson, Shibu Jacob, Pradeep Mathew Koshy, Gautam Rajan, Elenjickal Elias John, Smita Mary Matthai, L Jeyaseelan, Babu Ponnusamy, Terence Cook, Charles Pusey, Mohamed R Daha, John Feehally, Jonathan Barratt, Santosh Varughese
Protocol and rationale for the first South Asian 5-year prospective longitudinal observational cohort study and biomarker evaluation investigating the clinical course and risk profile of IgA nephropathy: GRACE IgANI cohort. Wellcome open research 3 (2018)
See Cheng Yeo, Chee Kay Cheung, Jonathan Barratt
New insights into the pathogenesis of IgA nephropathy. Pediatric nephrology (Berlin, Germany) 33 (5) (2017)
Matthew P M Graham-Brown, Cristina Vasilica, Tom Oates, Ben Light, Christian Clausner, Apostolos Antonacoloulos, Lydia Y J Chen, Paula Ormandy, Jonathan Barratt
Study protocol: responding to the needs of patients with IgA nephropathy, a social media approach. Clinical kidney journal 11 (4) (2017)
Haresh Selvaskandan, Izabella Pawluczyk, Jonathan Barratt
MicroRNAs: a new avenue to understand, investigate and treat immunoglobulin A nephropathy? Clinical kidney journal 11 (1) (2017)

Jonathan Barratt.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jonathan Barratt